NEW

  Last week, Billy Tauzin, a 66-year-old cancer survivor, and former Congressman from Louisiana, announced that he would be…

  In a recent edition of the Journal of Academic Medicine, Steven Kawczak and William Carey of the Cleveland…

A recent article from the Washington Legal Foundation (WLF), examined the trend of “pharmaceutical manufacturers becoming the…

A new development in the continuing trend of pharmaceutical company lawsuits occurred last week, when a “New Jersey appeals…

The recent trend of media and Congress to call drug and pharmaceutical companies the “bad guys,” like Wall Street and AIG, only…

  Last year, Laurence J. Hirsch, a former spokesman for the pharmaceutical manufacturer  Merck, wrote an 11-page…

Last week, the New Jersey Senate Health, Human Services and Senior Citizens Committee approved a bill—S-369—that  will…

In response to recent  joint hearings held by the Minnesota Commerce and Labor, and the Business, Industry and Jobs…

Last week Janet Woodcock, director of the Center for Drug Evaluation and Research at the FDA was cleared of a conflict of interest…

  A recent article in the Journal of the American Medical Association (JAMA), titled “Continuing Medical Education: Let the…